Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML. Blood advances El Chaer, F., Borate, U., Dulery, R., Holtan, S. G., Law, A. D., Muffly, L., Nassereddine, S., Shallis, R. M., Stringaris, K., Taylor, J., Devine, S. M., Mohty, M., Hourigan, C. S. 2021; 5 (6): 1757–59

View details for DOI 10.1182/bloodadvances.2020003839

View details for PubMedID 33755090